Xencor (XNCR) Return on Equity [ROE] (2014 - 2026)
Xencor's Return on Equity [ROE] came in at -32.06% for Q2 2026, down 4.59 percentage points from -27.47% a year earlier and down 2.11 percentage points from the prior quarter.
Xencor (XNCR) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Xencor's Return on Equity [ROE] was -14.07%, up 21.34 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -2.17 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -35.41% in FY2024 (-16.22 pp), -19.19% in FY2023 (-11.63 pp), -7.55% in FY2022 (-20.21 pp) and 12.65% in FY2021 (+24.55 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q1 2025.
- Year-over-year, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of -0.39 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2022 (a gain of 22.45 percentage points), and the weakest in Q1 2023 (a drop of 28.08 percentage points).
- Business Quant data shows XNCR's Return on Equity [ROE] at -29.95% (Q1 2026), -14.61% (Q4 2025) and -21.14% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Xencor | 1.85 Bn | 270.30 Mn | - | -32.06% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.06% |
| Mar 31, 2026 | -29.95% |
| Dec 31, 2025 | -14.61% |
| Sep 30, 2025 | -21.14% |
| Jun 30, 2025 | -27.47% |
| Mar 31, 2025 | -32.13% |
| Dec 31, 2024 | -34.28% |
| Sep 30, 2024 | -34.54% |
| Jun 30, 2024 | -33.69% |
| Mar 31, 2024 | -23.24% |
| Dec 31, 2023 | -20.03% |
| Sep 30, 2023 | -17.66% |
| Jun 30, 2023 | -18.72% |
| Mar 31, 2023 | -18.93% |
| Dec 31, 2022 | -6.39% |
| Sep 30, 2022 | 5.29% |
| Jun 30, 2022 | 4.16% |
| Mar 31, 2022 | 9.14% |
| Dec 31, 2021 | 3.89% |
| Sep 30, 2021 | -9.55% |
Xencor Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=XNCR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "XNCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=XNCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();